Israel’s Teva reaches potential $4.25 bn US opioid settlement
Israeli generic drug maker Teva has reached an settlement in precept to pay $4.25 billion over ...
Read moreDetails
Israeli generic drug maker Teva has reached an settlement in precept to pay $4.25 billion over ...
Read moreDetails